~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC)("Ensysce" or the "Company"), pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced the closing of a $4 million convertible […]

(NASDAQ:SILO), SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Allucent, a global full-service clinical research organization (CRO), to support the Company's final preparations and planned submission of its investigational new drug application

(NASDAQ:RXT), SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Rackspace Technology(R) (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, today announced the appointment of Lata Varghese as Senior Vice President of Business Transformation and Phani Kishore Burre, as Senior Vice President of Services and Delivery for the Public Cloud business unit. Lata

Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment on Phase 2b/3 trial design provides a clear regulatory path for two well-controlled studies under a single protocol, strengthening the Company's position with ophthalmology-focused strategics and

Iron Cap Group Introduces Next-Generation Market Access Engine for Rapid Activation GlobeNewswire November 17, 2025 PARIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — Iron Cap Group today unveiled its next-generation Market Access Engine, a system developed to minimize latency between account creation and market entry. The technology incorporates automated approval routing, intelligent verification layers, and load-optimized

Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation Strategic leadership additions position company to unlock growth and speed customer success GlobeNewswire November 17, 2025 SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Rackspace Technology(R) (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company,

Avocado Oil Market Size to Exceed USD 1,315.84 Million by 2034 | Towards FnB According to Towards FnB, the global avocado oil market size is evaluated at USD 686.32 million in 2025 and is expected to hit USD 1,315.84 million by 2034, reflecting at a CAGR of 7.5% from 2025 to 2034. The market has

Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings GlobeNewswire November 17, 2025 Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment on Phase 2b/3 trial

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD GlobeNewswire November 17, 2025 SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., today announced the recent publication of three peer-reviewed articles evaluating the efficacy and safety of adjunctive cenobamate in adult Asian patients with uncontrolled focal seizures. The articles are based on findings from